EUVIMEDEUVIMED entdecken
Crossref

In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice

Elias Adikwu, Simeon Ajeka Igono, Nwakaego Omonigho Ebong

American Journal of Biomedical Sciences · 2022-01 · 29-38

DOI: 10.5099/aj220100029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Biomedical Sciences, 2022-01. Verfasst von Elias Adikwu und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Adikwu, E., Igono, S. A., & Ebong, N. O. (2022). In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice. American Journal of Biomedical Sciences, 29-38. https://doi.org/10.5099/aj220100029

Vancouver

Adikwu E, Igono SA, Ebong NO. In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice. American Journal of Biomedical Sciences. 2022:29-38. doi:10.5099/aj220100029

BibTeX
@article{Adikwu2022,
  author = {Adikwu, Elias and Igono, Simeon Ajeka and Ebong, Nwakaego Omonigho},
  title = {In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice},
  journal = {American Journal of Biomedical Sciences},
  year = {2022},
  pages = {29--38},
  doi = {10.5099/aj220100029}
}
Kostenlos starten →